Impacts of the zero mark-up policy on hospitalization expenses of T2DM and cholecystolithiasis inpatients in SC province, western China: an interrupted time series analysis

BACKGROUND: Since 2009, a series of ambitious health system reforms have been launched in China, including the zero mark-up drug policy (ZMDP); the policy was intended to reduce substantial medicine expenses for patients by abolishing the 15% mark-up on drugs. This study aims to evaluate the impacts...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Xirui, Xiao, Yao, Liu, Huan, Li, Qinchuan, Jiang, Qian, Liu, Chun, Xie, Fangqing, Wang, Hongju, Yang, Fang, Han, Xiao, Yang, Hengbo, Yang, Yong, Ye, Yongqin, Gan, XiaoHong, Long, Enwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177657/
https://www.ncbi.nlm.nih.gov/pubmed/37188279
http://dx.doi.org/10.3389/fpubh.2023.1079655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177657/
https://www.ncbi.nlm.nih.gov/pubmed/37188279
http://dx.doi.org/10.3389/fpubh.2023.1079655

Ejemplares similares